Most people taking Mounjaro lose between 15% and 21% of their body weight over about 18 months, depending on the dose. For someone who weighs 230 pounds, that translates to roughly 35 to 48 pounds. These numbers come from the largest clinical trial of the drug, called SURMOUNT-1, which tracked over 2,500 adults with obesity for 72 weeks.
Weight Loss by Dose
Mounjaro comes in several dose strengths, and the amount of weight you lose scales with how high you go. In the SURMOUNT-1 trial, participants who took a placebo lost about 3% of their body weight over 72 weeks, mostly from the lifestyle changes that were part of the study. The results for the three treatment doses were significantly higher:
- 2.5 mg (starting dose): This is only used during the first four weeks to let your body adjust. It’s not meant to be a maintenance dose.
- 5 mg: 15% average body weight loss
- 10 mg: 19.5% average body weight loss
- 15 mg: 20.9% average body weight loss
Not everyone reaches the highest dose. Your prescriber will increase you by 2.5 mg increments every four weeks or longer, based on how you respond and what side effects you experience. Some people get strong results at 10 mg and stay there. Others need the full 15 mg to see meaningful progress. The jump from 10 mg to 15 mg adds only about 1.4 percentage points of additional weight loss on average, so the benefit of maxing out varies from person to person.
How Quickly the Weight Comes Off
Weight loss on Mounjaro begins within the first few weeks, but the early phase is slow by design. You spend at least your first month on the 2.5 mg starting dose, which is meant to ease your digestive system into the medication rather than produce dramatic results. Most people don’t reach a therapeutic dose (5 mg or higher) until month two at the earliest.
From there, the weight loss curve steepens. The most rapid period of loss typically falls between months two and nine as you titrate up through the doses. By the end of the 72-week trial period, results were still improving for many participants, though the rate of loss gradually slows as you approach a new stable weight. The full effect of the drug takes the better part of a year and a half to play out, so early results at month one or two aren’t a reliable predictor of where you’ll end up.
How Mounjaro Compares to Wegovy
Mounjaro outperforms Wegovy, the other major weight loss injection, by a meaningful margin. A head-to-head trial called SURMOUNT-5, published in The New England Journal of Medicine in May 2025, compared the two directly. Participants on Mounjaro lost an average of 50.3 pounds (20.2% of their body weight), while those on Wegovy lost 33 pounds (13.7%). That’s about 47% more weight loss with Mounjaro.
The difference comes down to how the drugs work. Wegovy targets a single gut hormone pathway called GLP-1, which slows digestion and reduces appetite. Mounjaro targets that same pathway but also activates a second one called GIP. This dual action appears to produce stronger appetite suppression and may improve how the body handles energy metabolism. Interestingly, Mounjaro’s activity on the GLP-1 pathway is actually weaker than drugs that target it directly, but this seems to be an advantage: it causes less receptor burnout over time, potentially keeping the drug effective longer.
Not Everyone Responds the Same Way
Averages can be misleading. While the headline numbers are impressive, roughly 10% to 15% of people in the clinical trials were “nonresponders” who lost less than 5% of their body weight. That’s a small minority, but it’s worth knowing that the drug doesn’t work equally well for everyone.
On the flip side, many participants exceeded the averages. Some people on the 15 mg dose lost 25% or more of their starting weight. Your individual results will depend on factors like your starting weight, metabolic health, diet, physical activity, and genetics that researchers are still working to fully understand. If you’re several months in and not seeing meaningful progress, that’s useful information for a conversation with your prescriber about whether to adjust your dose or explore other options.
What Happens If You Stop
This is the part most people don’t hear about upfront. A systematic review published in The Lancet found that one year after stopping GLP-1 drugs like Mounjaro, people regained about 60% of the weight they had lost during treatment. So if you lost 50 pounds on the medication, you could expect to regain roughly 30 of those pounds within a year of stopping.
This doesn’t mean the drug “doesn’t work.” It means obesity is a chronic condition, and the medication manages it rather than curing it, similar to how blood pressure medication controls hypertension without eliminating it permanently. Most people who achieve significant weight loss on Mounjaro will need to continue taking it long-term to maintain their results. That’s a significant commitment in terms of both cost and lifestyle, and it’s worth factoring into your expectations before starting.
Putting the Numbers in Perspective
To make these percentages concrete: a person starting at 250 pounds on the highest dose could expect to lose roughly 52 pounds over 18 months, bringing them to about 198 pounds. Someone starting at 200 pounds might lose around 42 pounds, landing near 158. These are averages, not guarantees, but they represent a scale of weight loss that was essentially impossible with previous medications, which typically produced 5% to 10% losses at best.
The clinical trial participants also made lifestyle changes alongside the medication, including dietary adjustments and increased physical activity. Mounjaro makes these changes easier by dramatically reducing hunger and food noise (the constant background thoughts about eating that many people with obesity experience), but the drug works best as part of a broader approach rather than as a standalone fix.